HOME Top Market Reports Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: January 2015
Report Code: BT 3042

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The plasma fractionation market is witnessing continuous growth. The rise in aging population worldwide is an important factor for this market, mainly because the risk of complications of hemophilia, such as inhibitor development, intracranial hemorrhage, and joint diseases, increases along with the age of a person. Therefore, the rise in aging population can add to the number of hemophilic patients worldwide, which drives the demand for plasma fractionation products such as factor VIII and factor IX, which are used to treat hemophilia. In addition, the increasing off-label use of albumin and immunoglobulin in various chronic diseases, increased diagnosis rate and rise in the use of prophylactic treatment for bleeding and immune diseases are expected to propel the growth of this market. However, the high cost of plasma fractionation products, serious adverse effects associated with plasma fractionation products, and emergence of recombinant products (which can be used as alternative to plasma-derived products) are hampering the growth of the global market to a certain extent.

North America is the largest regional segment of the global plasma fractionation market. However, the APAC and Latin American regions are expected to witness significant growth in the near future, primarily due to growth in the overall healthcare industry, growing disposable incomes in these regions, rising number of hemophilic patients, and increasing organ transplantations in these regions.

The global market for plasma fractionation is mainly dominated by six players that accounted for around 70% of the global market in 2013. However, new local players in the market are intensifying competition and thereby threatening the market share of existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve existing challenges and meet the needs of the market.

The major players in global market for plasma fractionation are Baxter International, Inc. (U.S.), Grifols SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Kedrion (Italy), Bio Product Laboratory (U.K.), Sanquin (Netherlands), Laboratoire Franηais du Fractionnement et des Biotechnologies (France), and Biotest (Germany).

Table of Contents 

1 Introduction (Page No. - 16)
  1.1 Objectives Of The Study
  1.2 Markets Covered
  1.3 Market Scope
  1.4 Stakeholders
  1.5 Years Considered In The Report
  1.6 Currency

2 Research Methodology (Page No. - 17)
  2.1 Research Approach
  2.2 Market Size Estimation
  2.3 Market Breakdown And Data Triangulation
  2.4 Market Share Estimation
  2.5 Key Secondary Sources
  2.6 Key Data From Primary Sources
      2.6.1 Key Industry Insights
  2.7 Assumptions For The Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 30)

5 Market Overview (Page No. - 31)
  5.1 Introduction
  5.2 Key Market Drivers
      5.2.1 Aging Baby Boomers Population Worldwide
      5.2.2 Rising Healthcare Expenditure
      5.2.3 Increasing Disposable Incomes In Developing Countries Creates Demand
  5.3 Key Market Restraints
      5.3.1 High Cost And Limited Reimbursement Poses A Major Barrier To The Growth Of The Plasma Fractionation Market
      5.3.2 Stringent Government Regulations
      5.3.3 Economic Slowdown And Saturation To Inhibit The Growth
      5.3.4 Rising Number Of Recombinant Products
  5.4 Key Market Opportunities
      5.4.1 Increasing Number Of Hemophilic Patients
  5.5 Key Market Challenges
      5.5.1 Pricing Pressure Faced By Prominent Players In The Market
  5.6 Key Market Trends
      5.6.1 Increasing Market Consolidation
      5.6.2 Rising Adoption Of Scig
      5.6.3 Rising Number Of Plasma Fractionation Collection Centers
      5.6.4 Increasing Number Of Local Players

6 Industry Insights (Page No. - 36)
  6.1 Introduction
  6.2 Porter’s Five Forces Analysis
      6.2.1 Threat Of New Entrants
      6.2.2 Threat Of Substitutes
      6.2.3 Bargaining Power Of Suppliers
      6.2.4 Bargaining Power Of Buyers
      6.2.5 Intensity Of Competitive Rivalry
  6.3 Strategic Benchmarking
      6.3.1 Expansions

7 Global Plasma Fractionation Market, By Product (Page No. - 42)
  7.1 Introduction
  7.2 Albumin
  7.3 Immunoglobulin
      7.3.1 Intravenous Immunoglobulin
      7.3.2 Subcutaneous Immunoglobulin
      7.3.3 Others
  7.4 Coagulation Factor Concentrates
      7.4.1 Factor VIII 
      7.4.2 Factor IX
      7.4.3 Factor XIII 
      7.4.4 Prothrombin Complex Concentrate
      7.4.5 Von Willebrand Factor (VWF)
      7.4.6 Fibrinogen Concentrates
  7.5 Protease Inhibitors
  7.6 Other Plasma Fractionation Products

8 Global Plasma Fractionation Market, By Application (Page No. - 50)
  8.1 Introduction
  8.2 Neurology
  8.3 Hematology
  8.4 Immunology
  8.5 Critical Care
  8.6 Others

9 Global Plasma Fractionation Market, By End User (Page No. - 54)
  9.1 Introduction
  9.2 Hospitals And Clinics
  9.3 Clinical Research Laboratories
  9.4 Academic Institutes

10 Global Plasma Fractionation Market, By Geography (Page No. - 57)
   10.1 Introduction
   10.2 North America
        10.2.1 U.S.
        10.2.2 Canada
   10.3 Europe
        10.3.1 Germany
        10.3.2 Italy
        10.3.3 Spain
        10.3.4 France
        10.3.5 U.K.
        10.3.6 Roe
   10.4 Asia-Pacific
        10.4.1 Japan
        10.4.2 China
        10.4.3 India
        10.4.4 Rest Of Asia-Pacific (RoAPAC)
   10.5 Rest Of The World
        10.5.1 Latin America
        10.5.2 Middle East And Africa

11 Competitive Landscape (Page No. - 79)
   11.1 Overview
   11.2 Market Share Analysis
   11.3 Competitive Situation And Trends
        11.3.1 New Product Launches
        11.3.2 Expansions
        11.3.3 Mergers And Acquisitions
        11.3.4 Agreements, Partnerships, Collaborations, & Joint Ventures
        11.3.5 Other Developments

12 Company Profiles (Page No. - 89)
   12.1 Baxter International, Inc.
        12.1.1 Business Overview
        12.1.2 Product Portfolio
        12.1.3 Key Strategy
        12.1.4 Recent Development
   12.2 Octapharma AG
        12.2.1 Business Overview
        12.2.2 Product Portfolio
        12.2.3 Key Strategy
        12.2.4 Recent Developments
   12.3 Biotest
        12.3.1 Business Overview
        12.3.2 Product Portfolio
        12.3.3 Key Strategy
        12.3.4 The Recent Developments
   12.4 Csl, Ltd.
        12.4.1 Business Overview
        12.4.2 Product Portfolio
        12.4.3 Key Strategy
        12.4.4 Recent Developments
   12.5 Grifols International SA
        12.5.1 Business Overview
        12.5.2 Product Portfolio
        12.5.3 Key Strategy
        12.5.4 Recent Developments
   12.6 Kedrion S.P.A.
        12.6.1 Business Overview
        12.6.2 Product Portfolio
        12.6.3 Key Strategy
        12.6.4 Recent Developments
   12.7 LFB SA
        12.7.1 Business Overview
        12.7.2 Product Portfolio
        12.7.3 Key Strategy
        12.7.4 Recent Developments
   12.8 Kedrion
        12.8.1 Business Overview
        12.8.2 Product Portfolio
        12.8.3 Key Strategy
        12.8.4 Recent Developments
   12.9 Chinese Biological Products, Inc.
        12.9.1 Business Overview
        12.9.2 Product Portfolio
        12.9.3 Key Strategy
        12.9.4 Recent Developments
   12.1 Shanghai Raas Blood Products Co., Ltd.
        12.10.1 Business Overview
        12.10.2 Product Portfolio
        12.10.3 Key Strategy
        12.10.4 Recent Developments

13 Appendix (Page No. - 116)
   13.1 Insights Of Industry Experts
   13.2 Discussion Guide
   13.3 Available Customizations
   13.4 Related Reports
   13.5 Introducing RT: Real-Time Market Intelligence 
  
List of Tables  (126 Tables)
   
Table 1 Demographic Growth Trends Of Elderly Population
Table 2 Global Plasma Fractionation  Market Size, By Product, 2012-2019 ($Million)
Table 3 Global Market Size, By Geography, 2012-2019 ($Million)
Table 4 Global Albumin  Market Size, By Geography, 2012-2019 ($Million)
Table 5 Global Immunoglobulin Market Size, By Type 2012-2019 ($Million)
Table 6 Global Immunoglobulin Market Size, By Geography 2012-2019 ($Million)
Table 7 Global Ivig Market Size, By Geography 2012-2019 ($Million)
Table 8 Global Scig Market Size, By Geography 2012-2019 ($Million)
Table 9 Global Others Immunoglobulin Market Size, By Geography 2012-2019 ($Million)
Table 10 Global Cogulation Factor Concentrates   Market Size, By Type 2012-2019 ($Million
Table 11 Global Cogulation Factor Concentrates Market Size, By Geography 2012-2019 ($Million)
Table 12 Global Factor Viii Market Size, By Geography 2012-2019 ($Miilion)
Table 13 Global Factor Ix Market Size, By Geography 2012-2019 ($Million)
Table 14 Global Factor Xiii Market Size, By Geography 2012-2019 ($Million)
Table 15 Global Pcc Market Size, By Geography 2012-2019 ($Million)
Table 16 Global Vwf Market Size, By Geography 2012-2019 ($Million)
Table 17 Fibrinogen Concentrates Market Size, By Geography 2012-2-19 ($Million)
Table 18 Global Protease Inhibitors  Market Size, By Geography 2012-19 ($Million)
Table 19 Global Other Plasma Fractionation Products Market Size, By Geography 2012-2019 ($Million)
Table 20 Plasma Fractionation Market Size, By Application 2012-2019 ($Million)
Table 21 Market Size, For Neurology, 2012-2019 ($Million)
Table 22 Market Size, For Hematology, 2012-2019 ($Million)
Table 23 Market Size, For Immunology, 2012-2019 ($Million)
Table 24 Market, For Critical Care, 2012-2019 ($Million)
Table 25 Market, For Others, 2012-2019 ($Million)
Table 26 Plasma Fractionation Market, By End Users, 2012-19 ($Million)
Table 27 Global Plasma Fractionation Market Size For Hospitals And Clinics, By Country/Region, 2012–2019 ($Million)
Table 28 Global Market Size For Clinical Research Laboratories, 2012-2019 ($Million)
Table 29 Global Plasma Fractionation Market Size For Academic Organizations, 2012-2019 ($Million)
Table 30 North America: Market Size, By Country, 2012–2019 ($Million)
Table 31 North America: Market Size, By Products, 2012–2019 ($Million)
Table 32 North America: Immunoglobulin Market Size, By Product, 2012–2019 ($Million)
Table 33 North America: Coagulation Factor Concentrates Market Size, By Product, 2012-2019 ($Million)
Table 34 North America: Plasma Fractionation Market Size, By Applications,  2012-2019 ($Million)
Table 35 North America: Market, By End User, 2012–2019 ($Million)
Table 36 U.S.: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 37 U.S.: Immunoglobulin Market Size, By Product, 2012–2019 ($Million)
Table 38 U.S.: Coagulation Factor Concentrates Market Size, By Product, 2012–2019 ($Million)
Table 39 U.S.: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 40 U.S.: Market Size, By End User, 2012–2019 ($Million)
Table 41 Canada: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 42 Canada: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 43 Canada: Coagulation Factor Concentrates Market Size, By Products, 2012–2019 ($Million)
Table 44 Canada: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 45 Canada: Market Size, By End Users, 2012-2019 ($Million)
Table 46 Europe: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 47 Europe: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 48 Europe: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 49 Europe: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 50 Europe: Market Size, By End Users, 2012-2019 ($Million)
Table 51 Germany: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 52 Germany: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 53 Germany: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
Table 54 Germany: Plasma Fractionation Market Size, By Applications, 2012–2019 ($Million)
Table 55 Germany: Market Size, By End User, 2012–2019 ($Million)
Table 56 Italy: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 57 Italy: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 58 Italy: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
Table 59 Italy: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 60 Italy: Market, By End User, 2012–2019 ($Million)
Table 61 Spain: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 62 Spain: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 63 Spain: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
Table 64 Spain: Plasma Fractionation Market Size, By Applications, 2012–2019 ($Million)
Table 65 Spain: Market, By End User, 2012–2019 ($Million)
Table 66 France: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 67 France: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 68 France: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 69 France: Plasma Fractionation Market Size, By Applications, 2012–2019 ($Million)
Table 70 France: Market Size, By End User, 2012–2019 ($Million)
Table 71 U.K.: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 72 U.K.:  Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 73 U.K.: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 74 U.K.: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 75 U.K.: Market Size, By End Users, 2012-2019 ($Million)
Table 76 ROE: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 77 ROE: Immunoglobulin Market Size, By Products, 2012-19 ($Million)
Table 78 ROE: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 79 ROE: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 80 ROE: Market Size, By End Users, 2012-2019 ($Million)
Table 81 Asia-Pacific: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 82 Asia-Pacific: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 83 Asia-Pacific: Coagulation Factor Concentrate Market Size, By Products, 2012-2019 ($Million)
Table 84 Asia-Pacific: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 85 Asia-Pacific: Market Size, By End Users, 2012-2019 ($Million)
Table 86 Japan: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 87 Japan: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 88 Japan: Coagulation Factor Concentrates Size, By Products, 2012-2019 ($Million)
Table 89 Japan: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 90 Japan: Market Size, By End Users, 2012-2019 ($Million)
Table 91 China: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 92 China: Immunological Market Size, By Products, 2012-19 ($Million)
Table 93 China: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 94 China: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 95 China: Market Size, By End Users, 2012-2019 ($Million)
Table 96 India: Plasma Fractionation Market Size, By Products 2012-19 ($Million)
Table 97 India: Immunoglobulin Market Size, By Products 2012-19 ($Million)
Table 98 India: Coagulation Factor Concentrates Market Size, By Products 2012-2019 ($Million)
Table 99 India: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 100 India: Plasma Fractionation Market Size, By Products 2012-2019 ($Million)
Table 101 Rest Of Asia-Pacific: Plasma Fractionation Market Size, By Products, 2012–2019 ($Million)
Table 102 Rest Of Asia-Pacific: Immunoglobulin Market Size, By Products, 2012–2019 ($Million)
Table 103 Rest Of Asia-Pacific: Coagulation Factor Concentrates Market Size, By Products, 2012–2019 ($Million)
Table 104 Rest Of Asia-Pacific: Plasma Fractionation Market Size, By Applications, 2012–2019 ($Million)
Table 105 Rest Of Asia-Pacific: Market Size, By End Users, 2012–2019 ($Million)
Table 106 ROW: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 107 ROW: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 108 ROW: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 109 ROW: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 110 ROW: Market Size, By End Users, 2012-2019 ($Million)
Table 111 Latin America: Market Size, By Products, 2012-2019 ($Million)
Table 112 Latin America: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 113 Latin America: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 114 Latin America: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
Table 115 Latin America: Market Size, By End Users, 2012-2019 ($Million)
Table 116 Middle East And Africa: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 117 Middle East And Africa: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
Table 118 Middle East And Africa: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
Table 119 Middle East And Africa: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
Table 120 Middle East And Africa: Market Size, By End Users, 2012-2019 ($Million)
Table 121 Growth Strategy Matrix, 2010–2014
Table 122 New Product Launches, 2011–2013
Table 123 Expansions, 2011–2014
Table 124 Mergers And Acquisitions, 2011–2014
Table 125 Agreements, Partnerships, Collaborations, And Joint Ventures, 2012–2014
Table 126 Other Developments, 2012–2014 
  
List of Figures  (38 Figures)
 
Figure 1 Research Methodology
Figure 2 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Evolution
Figure 7 Immunoglobulins To Dominate Market During Forecast Period
Figure 8 Major Markets Of Plasma Fractionation Market
Figure 9 Immunoglobulins Are The Fastest-Growing Segment During Forecast Period
Figure 10 Asia- Pacific To Grow At The Fastest Rate In The Next Five Years
Figure 11 Expansions, The Key Growth Strategy Adopted By Majority Of Leading Players To Sustain Their Market Share
Figure 12 Attractive Growth Opportunity In The Plasma Fractionation Market
Figure 13 Immunoglobulins Account For More Than One  Third Of The Apac Plasma Fractionation Market
Figure 14 U.S. Commands More Than One-Third Of The Global Market
Figure 15 North America Dominates The Market
Figure 16 Market Developed Vs. Developing Countries
Figure 17 Increased Consolidation For Improvement Of Product Portfolio Are The Leading Trends In This Industry
Figure 18 Porter’s Five Forces Analysis – Reference
Figure 19 Strategic Benchmarking: Grifols International Sa And Octapharma Ag Largely Adopted Organic Growth Strategies For Expansions
Figure 20 Hospital And Clinics Will Continue To Dominate The Global Market In 2012-2019
Figure 21 Geographic Snapshot (2014-2019) – Rapid Growth Markets Are Emerging As New Hot Spots
Figure 22 Immunoglobulin Offers High Growth Potential For Almost All Product Categories
Figure 23 North America Plasma Fractionation Market Snapshot: Growth Will Be Driven By Rising Demand For Plasma Fractionation Products And Development Of New Products Development
Figure 24 Germany Is The Major Market For Plasma Fractionation In Europe
Figure 25 Apac Plasma Fractionation Market Snapshot – China Is The Most Lucrative Market
Figure 26 Companies Adopted Expansion As A Key Growth Strategy
Figure 27 Global Plasma Fractionation Market Share Analysis, By Key Player, 2013
Figure 28 Battle For Market Share: Expansion Was The Key Strategy
Figure 29 Baxter International Inc.: Company Snapshot
Figure 30 Octapharma: Company Snapshot
Figure 31 Biotest: : Company Snapshot
Figure 32 Csl Ltd.: Company Snapshot
Figure 33 Grifols International Sa: Company Snapshot
Figure 34 Kedrion S.P.A.: Company Snapshot
Figure 35 Lfb Sa: Company Snapshot
Figure 36 Kedrion: Company Snapshot
Figure 37 Chinese Biological Products Inc.: Company Snapshot
Figure 38 Shanghai Raas Blood Products Co., Ltd. : Company Snapshot

The global market for plasma fractionation  is estimated to be worth around $16,573.4 million in 2014 and grow at a CAGR of 8.9% during the forecast period of 2014 to 2019. This market is mainly driven by increasing aging population, growing number of hemophilic patients, increased diagnosis rate, and growing prophylactic treatment. Moreover, the increasing off-label use of albumin and immunoglobulin in various chronic diseases is also contributing to market growth. However, the high cost and serious adverse effects of plasma fractionation products and the emergence of recombinant products are inhibiting market growth to a certain extent.

The global market for Plasma Fractionation is divided on the basis of product, application, and end user. Based on type of plasma fractionation product, the market is mainly segmented into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further subsegmented into intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), and others. Coagulation factor concentrates are subsegmented into factor VIII, factor IX, factor XIII, prothrombin coagulation concentrates, Von Willebrand factors, and fibrinogen concentrates. Various applications such as neurology, hematology, immunology, and critical care are analyzed in the report. By end users, the market is divided into the hospitals and clinics, clinical research laboratories, and academic institutes segments.

By region, the global market for Plasma Fractionation is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which are further analyzed at the country-level. The research report discusses the key market drivers and restraints of, and the opportunities in, the global market and its submarkets.

In 2013, in plasma fractionation products, the immunoglobulin segment accounted for the largest share of the market. This can be attributed to the increasing aging population with neurological and autoimmune disorders, off-label use, and prophylactic therapy of IVIg. In addition, IVIg is being used in a wide range of conditions such as adult respiratory distress syndrome, fibrosis, connective tissue disease, encephalitis, heart failure, and Alzheimer’s disease. Positive results in such application areas would increase the demand for IVIg in the future.

North America represented the largest regional market in 2013, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for the plasma fractionation, primarily due to the increasing aging population, growth in the overall healthcare industry, increasing use of immunoglobulins, improved economy, rising number of hemophilic patients, growing use of albumin in China, and increasing awareness of technologically advanced products in these regions.

Major players in the global market for Plasma Fractionation are Baxter International, Inc. (U.S.), Grifols SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Kedrion (Italy), Bio Product Laboratory (U.K.), Sanquin (Netherlands), Laboratoire Franηais du Fractionnement et des Biotechnologies  (France), and Biotest (Germany).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo Now